Menu Search
Equities

Archer Materials Ltd

38A:STU

Archer Materials Ltd

Actions
  • Price (EUR)0.25
  • Today's Change-0.008 / -3.10%
  • Shares traded0.00
  • 1 Year change+14.68%
  • Beta--
Data delayed at least 15 minutes, as of May 16 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Archer Materials Limited is an Australia-based technology company that operates within the semiconductor industry. The Company is developing advanced semiconductor devices, including chips relevant to quantum computing and medical diagnostics. The Company is progressing the development of its 12CQ quantum computing qubit processor chip (12CQ chip) and lab-on-a-chip biochip technology (biochip). The 12CQ chip is utilizing a carbon-based architecture that has the potential for practical qubit processing. It is focused on advancing its 12CQ chip technology towards integration with mobile devices. Its biochip development involves integrating graphene with miniaturized lab-on-a-chip platforms for advanced medical diagnostics. It is designing and building its biochip in clean-room facilities and engineering materials at the atom-scale. It also develops its biochip for digitizing biologically relevant signals like those from viruses or bacteria.

  • Revenue in AUD (TTM)985.11k
  • Net income in AUD-8.28m
  • Incorporated2007
  • Employees8.00
  • Location
    Archer Materials LtdLot Fourteen, Frome RoadADELAIDE 5000AustraliaAUS
  • Phone+61 88272-3288
  • Fax+61 88272-3888
  • Websitehttps://archerx.com.au/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.